1. 1801 Neoadjuvant chemotherapy with trastuzumab or lapatinib: Survival analysis of the HER2-positive cohort of the GeparQuinto study (GBG 44). (September 2015) Authors: Untch, M.; Von Minckwitz, G.; Gerber, B.; Eidtmann, H.; Rezai, M.; Fasching, P.A.; Tesch, H.; Eggemann, H.; Schrader, I.; Kittel, K.; Hanusch, C.; Huober, J.; Solbach, C.; Jackisch, C.; Kunz, G.; Blohmer, J.; Hauschild, M.; Fehm, T.; Nekljudova, V.; Loibl, S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 224 The DETECT study concept - circulating tumor cells (CTCs) in women with advanced breast cancer. (September 2015) Authors: Schochter, F.; Schramm, A.; Friedl, T.W.; Albrecht, S.; Jäger, B.; Huober, J.; Rack, B.; Trapp, E.; Fasching, P.A.; Taran, F.A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti-Müllerian hormone (AMH) levels in premenopausal breast cancer patients treated with taxane-based adjuvant chemotherapy – A translational research project of the SUCCESS A study. (October 2017) Authors: Trapp, Elisabeth; Steidl, J.; Rack, B.; Kupka, M.S.; Andergassen, U.; Jückstock, J.; Kurt, A.; Vilsmaier, T.; de Gregorio, A.; de Gregorio, N.; Tzschaschel, M.; Lato, C.; Polasik, A.; Tesch, H.; Schneeweiss, A.; Beckmann, M.W.; Fasching, P.A.; Janni, W.; Müller, V. Journal: Breast Issue: Volume 35(2017) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Characteristics and clinical outcome of breast cancer patients with asymptomatic brain metastases. (October 2020) Authors: Laakmann, E.; Witzel, I.; Neunhöffer, T.; Weide, R.; Schmidt, M.; Park-Simon, T.W.; Möbus, V.; Mundhenke, C.; Polasik, A.; Lübbe, K.; Hesse, T.; Riecke, K.; Thill, M.; Fasching, P.A.; Denkert, C.; Fehm, T.; Nekljudova, V.; Rey, J.; Loibl, S.; Müller, V. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Competitive analysis of pregnancy associated HLA-proteins in trophoblast and breast cancer tissue. (September 2015) Authors: Wuerfel, F.M.; Hein, A.; Strick, R.; Strissel, P.L.; Wachter, D.L.; Fasching, P.A.; Beckmann, M.W.; Ruebner, M. Journal: Journal of reproductive immunology Issue: Volume 111(2015) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients. (April 2020) Authors: Hack, C.C.; Häberle, L.; Brucker, S.Y.; Janni, W.; Volz, B.; Loehberg, C.R.; Hartkopf, A.D.; Walter, C.-B.; Baake, G.; Fridman, A.; Malter, W.; Wuerstlein, R.; Harbeck, N.; Hoffmann, O.; Kuemmel, S.; Martin, B.; Thomssen, C.; Graf, H.; Wolf, C.; Lux, M.P. Journal: Breast Issue: Volume 50(2020) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study. (June 2018) Authors: Nabieva, N.; Fehm, T.; Häberle, L.; de Waal, J.; Rezai, M.; Baier, B.; Baake, G.; Kolberg, H.-C.; Guggenberger, M.; Warm, M.; Harbeck, N.; Wuerstlein, R.; Deuker, J.-U.; Dall, P.; Richter, B.; Wachsmann, G.; Brucker, C.; Siebers, J.W.; Popovic, M.; Kuhn, T. Journal: European journal of cancer Issue: Volume 96(2018) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P176 The DETECT-study concept – circulating tumor cells (CTCs) in metastatic breast cancer. (March 2015) Authors: Schramm, A.; Mueller, V.; Huober, J.; Rack, B.; Fasching, P.A.; Taran, F.; Schneeweiss, A.; Aktas, B.; Janni, W.; Fehm, T. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S85 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial. (November 2018) Authors: Hurvitz, S.A.; Quek, R.G.W.; Turner, N.C.; Telli, M.L.; Rugo, H.S.; Mailliez, A.; Ettl, J.; Grischke, E.; Mina, L.A.; Balmaña, J.; Fasching, P.A.; Bhattacharyya, H.; Hannah, A.L.; Robson, M.E.; Wardley, A.M. Journal: European journal of cancer Issue: Volume 104(2018) Page Start: 160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system. (October 2020) Authors: Schmidt, M.; Degenhardt, T.; Fasching, P.A.; Lüftner, D.; Müller, V.; Thomssen, C.; Schem, C.; Witzel, I.; Decker, T.; Tesch, H.; Kümmel, S.; Uleer, C.; Würstlein, R.; Hoffmann, O.; Warm, M.; Marschner, N.; Kates, R.E.; Schumacher, J.; Harbeck, N. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗